Cover Image
Market Research Report

Rapid Influenza Diagnostic Tests Market Size By Product, By Patient, By End-use Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

Published by Global Market Insights Inc. Product code 913904
Published Content info 110 Pages
Delivery time: 2-3 business days
Price
Back to Top
Rapid Influenza Diagnostic Tests Market Size By Product, By Patient, By End-use Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
Published: September 6, 2019 Content info: 110 Pages
Description

Title:
Rapid Influenza Diagnostic Tests (RIDT) Market Size By Product (RIDT for Influenza A, RIDT for Influenza B), By Patient (Pediatric, Adult), By End-use (Hospitals, Diagnostics Centers, Research Laboratories) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Rapid Influenza Diagnostic Tests Market will exceed USD 689.0 million by 2025; as per a new research report.

Growing number of infectious diseases and viral infections across the world will boost the global rapid influenza diagnostic test market growth over forecast period. Rapid influenza diagnostic test (RIDT) are used for diagnosis and treatment of highly contagious diseases caused due to airborne route and physical contact. RIDT provides several advantages such as accurate detection and diagnosis of flu and other viral infections. Thus, increasing rate of viral infections and flu will significantly escalate the rapid influenza diagnostic tests market growth over the forecast timeframe.

Rise in global awareness of flu among geriatric population will result into lucrative growth of rapid influenza diagnostic tests market. According to the Centre for Disease Control and Prevention (CDC), around 9.3 to 49 million people suffer from influenza in the U.S. each year. Moreover, flu and seasonal viral infection are one of the most common disorders among men and women across the country, resulting in higher demand for better diagnostic and treatment, thereby boosting rapid influenza diagnostic tests market growth in the upcoming years.

However, stringent regulatory guideline for approval of new kits may act as restraint, thereby negatively impacting rapid influenza diagnostic test market growth in forthcoming years.

RIDT for influenza A segment held significant revenue size and was valued at USD 352.5 million in the year 2018 and is estimated to show similar trend over the forecast period. Increasing geriatric population coupled with rising prevalence of flu and infectious diseases will significantly impact the market growth. According to the World Health Organization (WHO), around 7 million adults suffered from influenza in 2018. Furthermore, increasing prevalence of diagnosis and treatment for influenza will impact the segmental growth during the forecast period.

Rapid influenza diagnostic tests for pediatric is estimated to grow at 7.5% in upcoming years. Increasing incidence of influenza among pediatric population will stimulate the industry growth in the upcoming years. According to the NSW Government, 192 per 100,000 children aged between 0-5 months require hospitalization every month. The severity of influenza in pediatric patients is more and results in high frequent hospitalizations as compared to the adults and geriatric population. Hence, growing influenza prevalence in pediatric patients will boost the rapid influenza diagnostic tests market growth in the forthcoming years.

Use of rapid influenza diagnostic tests in diagnostic centers held significant market share and was valued at USD 171.5 million in the year 2018. The market is estimated to grow at rapid rate owing to the rise in number of influenza testing among geriatric population and children. Rise in patient preference in diagnostic centers to undergo different pathological tests due to better diagnosis and convenience for treatment of flues and viral infections will augment the demand for rapid influenza diagnostic tests. In addition, advantages such as specialized services, and hospitalized infrastructure will further increase the demand for RIDT procedures in diagnostic centers, thereby enhancing the segmental growth over the upcoming years.

Canada rapid influenza diagnostic tests market is projected to expand at 7.3% over the forecast period due to increasing awareness and high hospitalization rate in the country. According to the Infection Control and Prevention Canada, approximately 55,000 patients suffered from influenza in year 2018. Thus, increasing awareness about prevention of flue, contagious diseases and common cold among the Canadian population along with robust spending on diagnosis and treatment of influenza will propel rapid influenza diagnostic tests market growth in the country.

India rapid influenza diagnostic test market held significant market share and was valued at USD 15.1 million in the year 2018 and is anticipated to foresees lucrative growth over the upcoming period owing to growing number of patients suffering from influenza. According to the National Centre for Biotechnology Information, approximately 30,000 patients suffered from influenza in year 2015. Hence, increase in prevalence of influenza in the country will boost the demand and adoption rate of rapid influenza diagnostic test, fueling the market growth over projected timeframe.

Some of the major market players involved in rapid influenza diagnostic tests market includes DiaSorin S.p, BD, SA Scientific, CorisBioconcep among other players. These market players implement several strategic initiatives such as partnerships, mergers, acquisitions, partnerships and new product launch in order to expand the geographic reach and sales of the company.

Table of Contents
Product Code: 4329

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Rapid influenza diagnostic tests industry 360 degree synopsis, 2014 - 2025 (USD Million)
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Patient trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Rapid Influenza Diagnostic Tests Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025 (USD Million)
  • 3.3. Industry impact factors
    • 3.3.1. Growth drivers
      • 3.3.1.1. Growing prevalence of influenza
      • 3.3.1.2. Increase in R&D activities
      • 3.3.1.3. Rise in demand for rapid diagnostic tests
      • 3.3.1.4. Greater specificity of rapid influenza diagnostic tests
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Lack of skilled professionals
      • 3.3.2.2. Stringent regulatory guidelines
      • 3.3.2.3. Rising healthcare costs
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By patient
    • 3.4.3. By end-use
  • 3.5. Porter's analysis
  • 3.6. Competitive landscape, 2018
    • 3.6.1. Strategy dashboard
  • 3.7. PESTEL analysis

Chapter 4. Rapid Influenza Diagnostic Tests Market, By Product

  • 4.1. Global rapid influenza diagnostic tests market share, by product, 2018 & 2025
  • 4.2. RIDT for Influenza A
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. RIDT for Influenza B
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Rapid Influenza Diagnostic Tests Market, By Patient

  • 5.1. Global rapid influenza diagnostic tests market share, by patient, 2018 & 2025
  • 5.2. Pediatric
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Adult
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Rapid Influenza Diagnostic Tests Market, By End-use

  • 6.1. Global rapid influenza diagnostic tests market share by end-use, 2018 & 2025
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Diagnostics centers
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.4. Research laboratories
    • 6.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.5. Others
    • 6.5.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Rapid Influenza Diagnostic Tests Market, By Region

  • 7.1. Global rapid influenza diagnostic tests market share, by region, 2018 & 2025
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by patient, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.2.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by patient, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.8. Spain
      • 7.3.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.3.9. Italy
      • 7.3.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by patient, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.7.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.4.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.8.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.4.8.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.9.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.4.9.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.5.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.5.3. Market size, by patient, 2014 - 2025 (USD Million)
    • 7.5.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.5.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.5.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.6.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.5.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.7.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.5.7.3. Market size, by end-use, 2014 - 2025 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.6.2. Market size, by product, 2014 - 2025 (USD Million)
    • 7.6.3. Market size, by patient, 2014 - 2025 (USD Million)
    • 7.6.4. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.5.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.6.5.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.6.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.6.6.3. Market size, by end-use, 2014 - 2025 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.7.2. Market size, by patient, 2014 - 2025 (USD Million)
      • 7.6.7.3. Market size, by end-use, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. DiaSorin S.p.A
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Becton, Dickinson and Company
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. SA Scientific
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. CorisBioconcep
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Meridian Bioscience Inc.
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Abbott
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Analytik Jena
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Roche
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Quidel Corporation
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Princeton BioMeditech Corporation
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis

Data Tables

  • TABLE 1. Rapid influenza diagnostic tests industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Global rapid influenza diagnostic tests market, 2014 - 2025 (USD Million)
  • TABLE 3. Global rapid influenza diagnostic tests market, by product, 2014 - 2025 (USD Million)
  • TABLE 4. Global rapid influenza diagnostic tests market, by patient, 2014- 2025 (USD Million)
  • TABLE 5. Global rapid influenza diagnostic tests market, by end-use, 2014- 2025 (USD Million)
  • TABLE 6. Global rapid influenza diagnostic tests market, by region, 2014 - 2025 (USD Million)
  • TABLE 7. Industry impact forces
  • TABLE 8. RIDT for Influenza A market size, by region, 2014 - 2025 (USD Million)
  • TABLE 9. RIDT for Influenza B market size, by region, 2014 - 2025 (USD Million)
  • TABLE 10. Pediatric market size, by region, 2014 - 2025 (USD Million)
  • TABLE 11. Adult market size, by region, 2014 - 2025 (USD Million)
  • TABLE 12. Hospitals market size, by region, 2014 - 2025 (USD Million)
  • TABLE 13. Diagnostic centers market size, by region, 2014 - 2025 (USD Million)
  • TABLE 14. Research labs market size, by region, 2014 - 2025 (USD Million)
  • TABLE 15. Others market size, by region, 2014 - 2025 (USD Million)
  • TABLE 16. North America rapid influenza diagnostic tests market size, by country, 2014 - 2025 (USD Million)
  • TABLE 17. North America rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 18. North America rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 19. North America rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 20. U.S. rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 21. U.S. rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 22. U.S. rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 23. Canada rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 24. Canada rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 25. Canada rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 26. Europe rapid influenza diagnostic tests market size, by country, 2014 - 2025 (USD Million)
  • TABLE 27. Europe rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 28. Europe rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 29. Europe rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 30. Germany rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 31. Germany rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 32. Germany rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 33. UK rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 34. UK rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 35. UK rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 36. France rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 37. France rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 38. France rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 39. Spain rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 40. Spain rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 41. Spain rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 42. Italy rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 43. Italy rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 44. Italy rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 45. Asia Pacific rapid influenza diagnostic tests market size, by country, 2014 - 2025 (USD Million)
  • TABLE 46. Asia Pacific rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 47. Asia Pacific rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 48. Asia Pacific rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 49. China rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 50. China rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 51. China rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 52. Japan rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 53. Japan rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 54. Japan rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 55. India rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 56. India rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 57. India rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 58. Australia rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 59. Australia rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 60. Australia rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 61. South Korea rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 62. South Korea rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 63. South Korea rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 64. Latin America rapid influenza diagnostic tests market size, by country, 2014 - 2025 (USD Million)
  • TABLE 65. Latin America rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 66. Latin America rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 67. Latin America rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 68. Brazil rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 69. Brazil rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 70. Brazil rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 71. Mexico rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 72. Mexico rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 73. Mexico rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 74. Argentina rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 75. Argentina rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 76. Argentina rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 77. MEA rapid influenza diagnostic tests market size, by country, 2014 - 2025 (USD Million)
  • TABLE 78. MEA rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 79. MEA rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 80. MEA rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 81. South Africa rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 82. South Africa rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 83. South Africa rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 84. Saudi Arabia rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 85. Mexico rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 86. Mexico rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)
  • TABLE 87. UAE rapid influenza diagnostic tests market size, by product, 2014 - 2025 (USD Million)
  • TABLE 88. UAE rapid influenza diagnostic tests market size, by patient, 2014 - 2025 (USD Million)
  • TABLE 89. UAE rapid influenza diagnostic tests market size, by end-use, 2014 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global rapid influenza diagnostic tests market, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by product
  • FIG. 4 Growth potential analysis, by patient
  • FIG. 5 Growth potential analysis, by end-use
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard
  • FIG. 8 PESTEL analysis
Back to Top